Bank of Montreal’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24M | Buy |
+493,743
| New | +$24M | 0.01% | 620 |
|
2024
Q4 | – | Sell |
-5,620
| Closed | -$266K | – | 3222 |
|
2024
Q3 | $266K | Sell |
5,620
-1,936
| -26% | -$91.6K | ﹤0.01% | 2556 |
|
2024
Q2 | $473K | Buy |
7,556
+1,574
| +26% | +$98.4K | ﹤0.01% | 2190 |
|
2024
Q1 | $434K | Buy |
5,982
+2,582
| +76% | +$187K | ﹤0.01% | 2256 |
|
2023
Q4 | $233K | Sell |
3,400
-1,837
| -35% | -$126K | ﹤0.01% | 2622 |
|
2023
Q3 | $267K | Sell |
5,237
-198
| -4% | -$10.1K | ﹤0.01% | 2498 |
|
2023
Q2 | $322K | Buy |
+5,435
| New | +$322K | ﹤0.01% | 2526 |
|
2022
Q4 | – | Sell |
-3,904
| Closed | -$265 | – | 3496 |
|
2022
Q3 | $265 | Sell |
3,904
-309
| -7% | -$21 | ﹤0.01% | 2604 |
|
2022
Q2 | $313 | Sell |
4,213
-115,742
| -96% | -$8.6K | ﹤0.01% | 2596 |
|
2022
Q1 | $7.75M | Buy |
119,955
+115,003
| +2,322% | +$7.43M | ﹤0.01% | 1039 |
|
2021
Q4 | $397K | Buy |
4,952
+1,256
| +34% | +$101K | ﹤0.01% | 2497 |
|
2021
Q3 | $416K | Buy |
3,696
+1,042
| +39% | +$117K | ﹤0.01% | 2785 |
|
2021
Q2 | $387K | Buy |
2,654
+1,232
| +87% | +$180K | ﹤0.01% | 2834 |
|
2021
Q1 | $171K | Sell |
1,422
-816
| -36% | -$98.1K | ﹤0.01% | 2813 |
|
2020
Q4 | $423K | Buy |
2,238
+2,190
| +4,563% | +$414K | ﹤0.01% | 2388 |
|
2020
Q3 | $4K | Sell |
48
-909
| -95% | -$75.8K | ﹤0.01% | 4070 |
|
2020
Q2 | $90K | Sell |
957
-1,407
| -60% | -$132K | ﹤0.01% | 2782 |
|
2020
Q1 | $93K | Sell |
2,364
-45,150
| -95% | -$1.78M | ﹤0.01% | 2347 |
|
2019
Q4 | $2.89M | Sell |
47,514
-32,566
| -41% | -$1.98M | ﹤0.01% | 1436 |
|
2019
Q3 | $3.28M | Sell |
80,080
-29,680
| -27% | -$1.22M | ﹤0.01% | 1196 |
|
2019
Q2 | $5.17M | Buy |
109,760
+13,750
| +14% | +$648K | ﹤0.01% | 1037 |
|
2019
Q1 | $3.43M | Buy |
96,010
+1,690
| +2% | +$60.4K | ﹤0.01% | 1208 |
|
2018
Q4 | $2.7M | Sell |
94,320
-5,613
| -6% | -$160K | ﹤0.01% | 1246 |
|
2018
Q3 | $4.43M | Buy |
99,933
+7,350
| +8% | +$326K | ﹤0.01% | 1158 |
|
2018
Q2 | $5.44M | Buy |
92,583
+47,850
| +107% | +$2.81M | ﹤0.01% | 1045 |
|
2018
Q1 | $2.05M | Buy |
44,733
+42,795
| +2,208% | +$1.96M | ﹤0.01% | 1452 |
|
2017
Q4 | $45K | Hold |
1,938
| – | – | ﹤0.01% | 2991 |
|
2017
Q3 | $34K | Buy |
1,938
+300
| +18% | +$5.26K | ﹤0.01% | 3089 |
|
2017
Q2 | $26K | Hold |
1,638
| – | – | ﹤0.01% | 3135 |
|
2017
Q1 | $36K | Buy |
+1,638
| New | +$36K | ﹤0.01% | 2927 |
|